These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9018389)

  • 21. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.
    Stern Y; Brandt J; Albert M; Jacobs DM; Liu X; Bell K; Marder K; Sano M; Albert S; Del-Castillo Castenada C; Bylsma F; Tycko B; Mayeux R
    Ann Neurol; 1997 May; 41(5):615-20. PubMed ID: 9153523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
    Sudo S; Shiozawa M; Cairns NJ; Wada Y
    J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multigenerational pedigree of late-onset Alzheimer's disease implies new genetic causes.
    Jimenez-Escrig A; Gomez-Tortosa E; Baron M; Rabano A; Arcos-Burgos M; Palacios LG; Yusta A; Anta P; Perez I; Hierro M; Munoz DG; Barquero S
    Brain; 2005 Jul; 128(Pt 7):1707-15. PubMed ID: 15843424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
    Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
    Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E and Alzheimer's disease.
    Strittmatter WJ; Roses AD
    Annu Rev Neurosci; 1996; 19():53-77. PubMed ID: 8833436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion.
    White F; Nicoll JA; Roses AD; Horsburgh K
    Neurobiol Dis; 2001 Aug; 8(4):611-25. PubMed ID: 11493026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E and the neuropathology of dementia.
    Itoh Y; Yamada M
    N Engl J Med; 1996 Feb; 334(9):599-600. PubMed ID: 8569837
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia.
    Bancher C; Egensperger R; Kösel S; Jellinger K; Graeber MB
    Acta Neuropathol; 1997 Nov; 94(5):403-9. PubMed ID: 9386771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype in diverse neurodegenerative disorders.
    Schneider JA; Gearing M; Robbins RS; de l'Aune W; Mirra SS
    Ann Neurol; 1995 Jul; 38(1):131-5. PubMed ID: 7611717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.
    Morris CM; Benjamin R; Leake A; McArthur FK; Candy JM; Ince PG; Torvik A; Bjertness E; Edwardson JA
    Neurosci Lett; 1995 Dec; 201(1):45-7. PubMed ID: 8830309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
    Landén M; Thorsell A; Wallin A; Blennow K
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease.
    Hardy J
    Am J Med Genet; 1995 Oct; 60(5):456-60. PubMed ID: 8546162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy.
    Tabaton M; Rolleri M; Masturzo P; Cammarata S; Angelini G; Hansen LA; Saitoh T; Petersen RB; Perry G; Richey P
    Neurology; 1995 Sep; 45(9):1764-5. PubMed ID: 7675243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
    Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
    Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The apolipoprotein E epsilon 4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 or 692 mutations.
    Haan J; Van Broeckhoven C; van Duijn CM; Voorhoeve E; van Harskamp F; van Swieten JC; Maat-Schieman ML; Roos RA; Bakker E
    Ann Neurol; 1994 Sep; 36(3):434-7. PubMed ID: 8080251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
    Ohm TG; Scharnagl H; März W; Bohl J
    Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.